Grove Bank & Trust’s Zimmer Biomet ZBH Stock Holding History

Grove Bank & Trust’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.8K	Hold	404	–	–	﹤0.01%	488
2026 Q1	$36.5K	Hold	404	–	–	﹤0.01%	459
2025 Q4	$36.3K	Buy	404 +328	+432%	+$31.1K	﹤0.01%	460
2025 Q3	$7.49K	Sell	76 -8	-10%	-$793	﹤0.01%	654
2025 Q2	$7.66K	Buy	84 +10	+14%	+$967	﹤0.01%	648
2025 Q1	$8.38K	Hold	74	–	–	﹤0.01%	606
2024 Q4	$7.82K	Buy	74 +33	+80%	+$3.54K	﹤0.01%	550
2024 Q3	$4.43K	Buy	+41	New	+$4.47K	﹤0.01%	558
2023 Q3	–	Sell	-39	Closed	-$5.68K	–	795
2023 Q2	$5.68K	Hold	39	–	–	﹤0.01%	539
2023 Q1	$5.04K	Buy	+39	New	+$4.9K	﹤0.01%	564
2018 Q1	–	Sell	-659	Closed	-$77K	–	466
2017 Q4	$77K	Sell	659 -626	-49%	-$70.8K	0.03%	250
2017 Q3	$146K	Sell	1,285 -70	-5%	-$8.08K	0.07%	186
2017 Q2	$169K	Buy	1,355 +1,051	+346%	+$125K	0.11%	145
2017 Q1	$36K	Sell	304 -201	-40%	-$22.8K	0.03%	248
2016 Q4	$51K	Buy	+505	New	+$54.1K	0.04%	214
2016 Q1	–	Sell	-118	Closed	-$12K	–	334
2015 Q4	$12K	Buy	+118	New	+$11.5K	0.01%	265

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Grove Bank & Trust's ZBH Position: Q2 2026 in Review

Grove Bank & Trust held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 404 shares worth $34.8K. The position accounts for ﹤0.01% of the portfolio, ranked #488.

Grove Bank & Trust first reported a position in ZBH in Q4 2015 and has held it in 16 quarters since. The position peaked at $169K in Q2 2017. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Grove Bank & Trust held 404 shares of Zimmer Biomet worth $34.8K as of Q2 2026.
Grove Bank & Trust left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #488 holding.
Grove Bank & Trust first reported a position in Zimmer Biomet in Q4 2015 and has held it in 16 quarters since.
Grove Bank & Trust's Zimmer Biomet position peaked at $169K in Q2 2017.
132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.